An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression
About This Grant
PROJECT SUMMARY Regulatory DNA elements, including enhancers and promoters, encode multiple transcription factor binding sites (TFBS) that quantitatively tune gene expression in a cell-type specific fashion. Understanding and engineering regulatory DNA could unlock new therapeutic approaches — for example, to restore proper expression of a disease gene. Yet, we have lacked computational models to predict which sequence changes to regulatory DNA will have which effects on gene expression as well as lacked experimental tools to test these predictions in a sufficiently scalable fashion. Our team has now developed innovative tools to dramatically increase the throughput of characterizing edits to regulatory DNA — including computational tools to optimize sequences to achieve desired gene expression outcomes, and experimental tools to test their impact on gene expression in high-throughput screens. We will further develop and apply this toolkit in the context of studying 4 genes for different diseases where genome editing therapies could be transformative. In Aim 1, we will use CRISPR prime editing to rewrite TFBS in gene promoters to achieve quantitative tuning of gene expression. In Aim 2, we will modulate gene expression through insertion of libraries of candidate enhancers and silencers at defined distances from gene promoters. In Aim 3, we will engineer sequence edits in cardiac organoids and measure the cell type specificity of their effects using novel single-cell readout approaches. Together, these studies will (i) illuminate basic mechanisms of gene regulation, (ii) map the programmability of 5 disease genes with distinct properties, and (iii) hone a novel integrative genomics toolkit to design and test edits to regulatory DNA to achieve specific gene expression outcomes. This approach will advance our understanding of genome regulation and lay the foundations for rational approaches to reprogram gene expression to treat many types of human diseases.
Grant Summary
An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression is a NHLBI - National Heart Lung and Blood Institute grant providing up to $770K for university, nonprofit, healthcare org. Applications are due 2030-03-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $770K
2030-03-31
- 1Confirm your organization is eligible for An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression from NHLBI - National Heart Lung and Blood Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NHLBI - National Heart Lung and Blood Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NHLBI - National Heart Lung and Blood Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression: Frequently Asked Questions
Who is eligible for the An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression?
An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression is offered by NHLBI - National Heart Lung and Blood Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression provide?
An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression provides up to $770K per award from NHLBI - National Heart Lung and Blood Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression deadline?
Applications for An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression are due 2030-03-31 (open). Because deadlines can change, verify the date with the funder, NHLBI - National Heart Lung and Blood Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression?
To apply for An integrative genomics toolkit for rewriting regulatory DNA to reprogram gene expression, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NHLBI - National Heart Lung and Blood Institute.